Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity

被引:0
作者
Roberta Torcasio
Maria Eugenia Gallo Cantafio
Claudia Veneziano
Carmela De Marco
Ludovica Ganino
Ilenia Valentino
Maria Antonietta Occhiuzzi
Ida Daniela Perrotta
Teresa Mancuso
Filomena Conforti
Bruno Rizzuti
Enrica Antonia Martino
Massimo Gentile
Antonino Neri
Giuseppe Viglietto
Fedora Grande
Nicola Amodio
机构
[1] University Magna Graecia of Catanzaro,Department of Experimental and Clinical Medicine
[2] University of Calabria,Department of Biology, Ecology and Earth Sciences
[3] University of Calabria,Department of Pharmacy, Health and Nutritional Sciences
[4] University of Calabria,Department of Biology, Ecology and Earth Sciences, Centre for Microscopy and Microanalysis
[5] Annunziata” Regional Hospital Cosenza,SS Rende (CS), Department of Physics
[6] CNR-NANOTEC,Institute for Biocomputation and Physics of Complex Systems (BIFI), Joint Unit GBsC
[7] University of Calabria,CSIC
[8] University of Zaragoza,BIFI
[9] IRCCS Di Reggio Emilia,Scientific Directorate
来源
Journal of Translational Medicine | / 22卷
关键词
Flavanones; Hesperitin; Naringenin; Mitochondrial dynamics; Multiple myeloma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585
    Stuehmer, Thorsten
    Arts, Janine
    Chatterjee, Manik
    Borawski, Johanna
    Wolff, Andre
    King, Peter
    Einsele, Hermann
    Leo, Eugen
    Bargou, Ralf C.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (04) : 529 - 536
  • [32] Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
    Leivas, Alejandra
    Perez-Martinez, Antonio
    Jesus Blanchard, Maria
    Martin-Clavero, Estela
    Fernandez, Lucia
    Jose Lahuerta, Juan
    Martinez-Lopez, Joaquin
    [J]. ONCOIMMUNOLOGY, 2016, 5 (12):
  • [33] Intracellular NAD+ depletion enhances bortezomib-induced anti-myeloma activity
    Cagnetta, Antonia
    Cea, Michele
    Calimeri, Teresa
    Acharya, Chirag
    Fulciniti, Mariateresa
    Tai, Yu-Tzu
    Hideshima, Teru
    Chauhan, Dharminder
    Zhong, Mike Y.
    Patrone, Franco
    Nencioni, Alessio
    Gobbi, Marco
    Richardson, Paul
    Munshi, Nikhil
    Anderson, Kenneth C.
    [J]. BLOOD, 2013, 122 (07) : 1243 - 1255
  • [34] Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity
    Fujii, Shiro
    Nakamura, Shingen
    Oda, Asuka
    Miki, Hirokazu
    Tenshin, Hirofumi
    Teramachi, Jumpei
    Hiasa, Masahiro
    Bat-Erdene, Ariunzaya
    Maeda, Yusaku
    Oura, Masahiro
    Takahashi, Mamiko
    Iwasa, Masami
    Endo, Itsuro
    Yoshida, Sumiko
    Aihara, Ken-ichi
    Kurahashi, Kiyoe
    Harada, Takeshi
    Kagawa, Kumiko
    Nakao, Michiyasu
    Sano, Shigeki
    Abe, Masahiro
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (02) : 246 - 258
  • [35] KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts
    Miki, Hirokazu
    Ozaki, Shuji
    Nakamura, Shingen
    Oda, Asuka
    Amou, Hiroe
    Ikegame, Akishige
    Watanabe, Keiichiro
    Hiasa, Masahiro
    Cui, Qu
    Harada, Takeshi
    Fujii, Shiro
    Nakano, Ayako
    Kagawa, Kumiko
    Takeuchi, Kyoko
    Yata, Ken-ichiro
    Sakai, Akira
    Abe, Masahiro
    Matsumoto, Toshio
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (03) : 328 - 339
  • [36] The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells
    Chen, Gege
    Xu, Zhijian
    Chang, Gaomei
    Hou, Jun
    Hu, Liangning
    Zhang, Yiwen
    Yu, Dandan
    Li, Bo
    Chang, Shuaikang
    Xie, Yongsheng
    Zhang, Yong
    Wei, Rong
    Wu, Huiqun
    Xiao, Wenqin
    Sun, Xi
    Tao, Yi
    Gao, Lu
    Dai, Bojie
    Shi, Jumei
    Zhu, Weiliang
    [J]. ONCOLOGY REPORTS, 2017, 38 (01) : 488 - 496
  • [37] miRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc
    Saha, Manujendra N.
    Abdi, Jahangir
    Yang, Yijun
    Chang, Hong
    [J]. ONCOTARGET, 2016, 7 (06) : 7149 - 7160
  • [38] Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment
    Zhou, Jihao
    Shen, Qi
    Lin, Haiqing
    Hu, Lina
    Li, Guoqiang
    Zhang, Xinyou
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (02) : 329 - 336
  • [39] Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models
    Zi, Fu-Ming
    He, Jing-Song
    Li, Yi
    Wu, Cai
    Yang, Li
    Yang, Yang
    Wang, Li-Juan
    He, Dong-Hua
    Zhao, Yi
    Wu, Wen-Jun
    Zheng, Gao-Feng
    Han, Xiao-Yan
    Huang, He
    Yi, Qing
    Cai, Zhen
    [J]. CANCER LETTERS, 2015, 356 (02) : 443 - 453
  • [40] Targeting ubiquitin-specific protease-7 in plasmacytoid dendritic cells triggers anti-myeloma immunity
    Ray, Arghya
    Du, Ting
    Song, Yan
    Buhrlage, Sara J.
    Chauhan, Dharminder
    Anderson, Kenneth C.
    [J]. LEUKEMIA, 2021, 35 (08) : 2435 - 2438